相关实验视频

Updated: Jun 7, 2025

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

在乳头甲状腺癌中与淋巴结转移相关的危险因素:基于2,428例病例的回顾性分析

Kejie Yu¹, Xianjiang Wu¹, Lei Dai¹

¹Department of Thyroid Surgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.

Frontiers in oncology

|November 21, 2024

概括

识别男性性别,年轻年龄,较大的瘤大小和多焦点性等危险因素可以帮助预测乳头甲状腺癌 (PTC) 中的淋巴结转移. 这有助于评估复发风险,并指导PTC患者的手术决策.

科学领域:

在瘤学瘤学.
手术病理学手术病理学
内分泌学在内分泌学.

背景情况:

淋巴结转移的乳头甲状腺癌 (PTC) 具有术后复发的高风险.
了解LNM的临床预测因素对于手术规划和PTC患者的风险分层至关重要.

研究的目的:

确定与乳腺状甲状腺癌 (PTC) 中的淋巴结转移 (LNM) 相关的独立临床风险因素.
为评估LNM可能性和指导PTC管理中的手术干预提供见解.

主要方法:

从2,428名接受初始甲状腺手术的PTC患者的临床数据的回顾性分析.
使用单变量和多变量二进制逻辑回归分析来研究中枢淋巴结转移 (CLNM),侧侧淋巴结转移 (LLNM) 和跳转转移的风险因素.

主要成果:

男性性别,年龄<45岁,最大轴直径 (MAD) >1厘米,多焦点被确定为CLNM的独立风险因素.
MAD>1厘米,多焦点性和CLNM是LLNM的独立预测因素. 瘤的位置 (下与上极) 也影响了转移模式.

结论:

在PTC中LNM的关键预测因素包括男性性别,年龄<45岁,MAD>1厘米,多焦点性和CLNM.
这些发现可以帮助预测LNM风险,在特定的PTC病例中潜在地指导选择性淋巴切除术.

关键词:

中枢淋巴结转移的转移.侧侧淋巴结转移的发生.皮囊性甲状腺癌是什么?风险因素的风险因素是什么跳过转移的转移.

更多相关视频

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...